New strategies in hepatocellular carcinoma: genomic prognostic markers. - Test2 - elhamkhani - TriplyDB

New strategies in hepatocellular carcinoma: genomic prognostic markers.

New strategies in hepatocellular carcinoma: genomic prognostic markers.

http://www.wikidata.org/entity/Q36090222

about

Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma Targeting the insulin-like growth factor pathway in hepatocellular carcinoma Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.CD44 expression in patients with combined hepatocellular cholangiocarcinoma.Molecular Determinants of Prognosis in Hepatocellular Carcinoma.Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study.Lactate Dehydrogenase Is an Important Prognostic Indicator for Hepatocellular Carcinoma after Partial Hepatectomy.Microenvironments dictating tumor cell dormancy Preoperative mean corpuscular hemoglobin affecting long-term outcomes of hepatectomized patients with hepatocellular carcinoma.Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma.Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation?Targeted therapies for hepatocellular carcinoma.Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression.Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.Translational medicine in hepatocellular carcinoma.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Modulation of immune responses following solid organ transplantation by microRNA.Liver transplantation for malignancies.Long non-coding RNA colon cancer-associated transcript 1 functions as a competing endogenous RNA to regulate cyclin-dependent kinase 1 expression by sponging miR-490-3p in hepatocellular carcinoma progression.Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.De Novo Emergence of Mesenchymal Stem-Like CD105+ Cancer Cells by Cytotoxic Agents in Human Hepatocellular Carcinoma.Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway.The role of liver cancer stem cells in donor liver allocation for patients with hepatocellular carcinoma.Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues.Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma.Grand Challenges and Opportunities in Deciphering the Role of Non-Coding RNAs in Human Diseases.

P2860

Q24316017-11EEA416-DDC3-4985-91CE-150B8DC615D0 Q27006846-6339F5A4-C5F3-4A5A-B041-EEAA6B2FD8DA Q27023524-B388AB4D-B31D-43F2-9C68-7C1ACF806292 Q31037974-C15CDF84-4349-47D9-B391-4930220AB8E2 Q33683019-6BAD05B4-D646-41FA-BD3B-A73A6534DE9C Q33820376-638985AF-8D2D-43CF-B5D9-11722E8D0660 Q34079695-4D7A8F1B-5BE1-4E68-8D3E-5F33BA733286 Q34187221-E6A2F65A-B84B-4BB4-BA1D-1CBB95D43F48 Q34323663-52D764C3-1FC6-47BC-A595-8C78C13ABF53 Q35187751-5F03F795-8EB7-4D2B-A9A8-3AA257EB70FD Q35584162-03C58077-649B-44BC-9C5B-85603EB974E8 Q35654057-FB55AA76-496A-4A49-920B-B2CA2CD75E87 Q35782494-AEB4D518-63EB-4A08-9F73-3E697B033EB5 Q35905975-90C7C4A1-65F1-4558-9A21-605B8B192472 Q36226478-9826274B-EB5C-4AB2-8169-B3F542AFE644 Q36309974-1DABDEFC-25CD-42BE-B032-9FEF5B248561 Q36427506-75E23452-BCDA-42CE-A810-9AE6B5488D5F Q36450759-E803D5A8-C03A-4D45-B6A6-101BE38C3A46 Q36523881-020900FB-3CAC-4E29-8939-2214F5BD73EB Q36625697-F2C3A538-51DA-418A-B6CE-66287834B878 Q36866382-12FB401E-A6AD-4523-AE9F-D4E37748FB4E Q36866385-ED82D503-CF79-4397-A667-BF403AD44BBB Q36875442-6F3000D8-827B-4C14-BED6-14497583AD58 Q36928888-FAD44A52-CCD4-4028-B511-399DE0E90D01 Q37111149-6916FF19-B404-4396-B991-B4716BEFA72E Q37178647-AFB0865D-7369-4832-96A5-E74CDCF3CD1A Q37952030-6DCA209C-1D48-4461-9A38-34C656C8C2FD Q38008950-73A4CE98-FB90-448E-B5DA-9A0B92B1523D Q38046452-8B4F6FD8-45CB-4497-B714-66CFAFA9AF60 Q38049411-515A4F7F-2854-48A6-AED6-E6F00C1CB0B1 Q38194071-BEAA185D-9A87-47D7-8EF6-953010F3DE2D Q38708776-F5E32973-DEC1-40C9-8646-B12C35AF2D16 Q38798431-3ED074F0-E5FE-4C3D-A159-0DC6DDE82B6F Q38969367-DA777C49-3BB7-4307-865F-69655290717D Q39215878-05FE12CA-57F1-4D32-AE8C-8222B70188DF Q39251789-CB412BBD-98EE-4CDF-A90E-3D8A6B9D5960 Q39319551-AA8FA8B1-85B8-4795-BF6B-417B15D54863 Q39358186-699CBF59-ECE0-4C9A-B139-850EA2566747 Q39674275-EB551906-DCCC-40E7-889B-9B61616CAAA8 Q40737717-97138D6E-5DF6-42DF-A431-CF8380FF0E84

P2860

New strategies in hepatocellular carcinoma: genomic prognostic markers.

http://www.wikidata.org/entity/Q36090222

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

New strategies in hepatocellular carcinoma: genomic prognostic markers.

@ast

New strategies in hepatocellular carcinoma: genomic prognostic markers.

@en

type

label

New strategies in hepatocellular carcinoma: genomic prognostic markers.

@ast

New strategies in hepatocellular carcinoma: genomic prognostic markers.

@en

prefLabel

New strategies in hepatocellular carcinoma: genomic prognostic markers.

@ast

New strategies in hepatocellular carcinoma: genomic prognostic markers.

@en

P1433

Q36090222-DCE70A2C-A4F0-4F83-9C3F-472323133FC0

P1476

Q36090222-85CCC1F8-A7D4-41AB-9807-FD142658E624

P2093

Q36090222-2E067966-2501-479E-BD0A-1754164197BC

Q36090222-3D74CAD6-B8D0-43F4-8C6D-F4D7A6CAA9DC

Q36090222-67B90056-89D4-424D-BB2B-9FAE71ECECAE

Q36090222-88567A98-5585-4823-AE5B-B45B8656DD71

Q36090222-8B89FFF5-9166-45D3-B72B-01B2D5A4D16C

Q36090222-9B010B59-CEFE-4103-A51C-27539341CBDF

P2860

Q36090222-00BD0F72-6864-4956-952A-49546F8ED65F

Q36090222-05828809-22EB-49D8-AED1-A5A1C0C7E4D3

Q36090222-068E76C7-481A-43CB-831D-A337FBD85BEA

Q36090222-071F0D9D-6810-4095-8FD5-B938F8650BF5

Q36090222-0986CD6C-0E73-4E2B-A66B-9AF4285A4664

Q36090222-0B93B7C8-576C-4C90-B1C3-A82329D76FC7

Q36090222-0C2123B3-6BCA-4752-94B4-60BAF9DD041A

Q36090222-1085A973-195B-403A-A3C2-B6D574E6853B

Q36090222-10DE6D07-6590-4953-9F4F-DBB121AF0819

Q36090222-1247704F-4549-4786-8F17-2D30FED1B5DD

P304

Q36090222-FE212F2A-79D1-4D40-B91C-6BFEE0607203

P31

Q36090222-DD5E5E2E-9C6F-4CF4-B4EC-BCEA8F0012C2

P356

Q36090222-442F3889-4A44-4DBC-BC25-5EDADBA7253A

P407

Q36090222-282414CA-AB3F-4B0C-A889-3F4543BE53D4

P433

Q36090222-0E57CB27-9941-47FD-92D8-C1655906A26D

P478

Q36090222-5B8965DF-C865-4683-9C67-240C8D1403FE

P50

Q36090222-2438BD32-4929-4940-8823-350082914F9E

Q36090222-3500FC55-02CF-4FF4-AED4-7FA92069158B

P577

Q36090222-07CBB27E-B8A8-40B8-A6FC-F2501B870C6D

P698

Q36090222-9D556107-DDA0-4FDB-B0F9-AFAC62E20DBF

P932

Q36090222-47A2E06F-90FF-43B6-A58C-C3338031296E

P356

1078-0432.CCR-09-1811

P1433

Clinical Cancer Research

P1476

New strategies in hepatocellular carcinoma: genomic prognostic markers

@en

P2093

Anja Lachenmayer

http://www.w3.org/2001/XMLSchema#string

Clara Alsinet

http://www.w3.org/2001/XMLSchema#string

Helena Cornella

http://www.w3.org/2001/XMLSchema#string

Radoslav Savic

http://www.w3.org/2001/XMLSchema#string

Sara Toffanin

http://www.w3.org/2001/XMLSchema#string

Yujin Hoshida

http://www.w3.org/2001/XMLSchema#string

P2860

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

MicroRNA expression, survival, and response to interferon in liver cancer

High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Silencing of microRNAs in vivo with 'antagomirs'

Sorafenib in advanced hepatocellular carcinoma

MicroRNA expression profiles classify human cancers

P304

4688-4694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-1811

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Josep M. Llovet

Augusto Villanueva

P577

2010-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20713493

http://www.w3.org/2001/XMLSchema#string

P932

3395071

http://www.w3.org/2001/XMLSchema#string